Covered recipient · General Payments record
SABY GEORGE
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$264,196.70
- Reported across 219 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $14,469.50 | 6 |
| Education | $2,607.00 | 2 |
| Food and Beverage | $1,070.34 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $10,581.45 | 6 |
| EISAI INC. | $2,410.23 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $2,142.00 | 1 |
| Janssen Global Services, LLC | $2,025.00 | 1 |
| Exelixis Inc. | $377.35 | 5 |
| AVEO Pharmaceuticals, Inc. | $235.41 | 2 |
| PFIZER INC. | $158.08 | 2 |
| Merck Sharp & Dohme Corporation | $140.51 | 2 |
| Janssen Scientific Affairs, LLC | $76.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Aveo Pharmaceuticals, Inc. | $134.87 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143485774 | CMS |
| Aveo Pharmaceuticals, Inc. | $100.54 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143485785 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $2,142.00 | 11/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1086114496 | CMS |
| E.R. Squibb & Sons, L.L.C. | $26.95 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101313485 | CMS |
| E.R. Squibb & Sons, L.L.C. | $907.00 | 01/11/2024 | Education | Undisputed | 01/23/2026 | 1101313551 | CMS |
| E.R. Squibb & Sons, L.L.C. | $1,700.00 | 04/26/2024 | Education | Undisputed | 01/23/2026 | 1101313549 | CMS |
| E.R. Squibb & Sons, L.L.C. | $2,200.00 | 06/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101313489 | CMS |
| E.R. Squibb & Sons, L.L.C. | $1,650.00 | 07/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101313501 | CMS |
| E.R. Squibb & Sons, L.L.C. | $4,097.50 | 12/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101313541 | CMS |
| Eisai Inc. | $35.72 | 11/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110778671 | CMS |
| Eisai Inc. | $19.51 | 11/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110778673 | CMS |
| Eisai Inc. | $2,355.00 | 12/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110778675 | CMS |
| Exelixis Inc. | $59.02 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138564958 | CMS |
| Exelixis Inc. | $55.21 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138564960 | CMS |
| Exelixis Inc. | $44.10 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138564962 | CMS |
| Exelixis Inc. | $73.19 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138564964 | CMS |
| Exelixis Inc. | $145.83 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138564966 | CMS |
| Janssen Global Services, LLC | $2,025.00 | 11/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077591973 | CMS |
| Janssen Scientific Affairs, LLC | $76.81 | 06/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078855242 | CMS |
| Merck Sharp & Dohme LLC | $80.38 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141674273 | CMS |
| Merck Sharp & Dohme LLC | $60.13 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141674275 | CMS |
| PFIZER INC. | $135.00 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131610466 | CMS |
| PFIZER INC. | $23.08 | 11/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131610470 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.